High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Very Premature Infants: a Prospective Observational Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Premature; Infant
- Sponsor
- Charles University, Czech Republic
- Enrollment
- 65
- Locations
- 1
- Primary Endpoint
- HFNC slabilization
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.
Investigators
Jonáš Klára
Principal Investigator
Charles University, Czech Republic
Eligibility Criteria
Inclusion Criteria
- •Preterm infants born between 28+0 and 31+6 gestational weeks were enrolled in the study after obtaining parental informed consent.
Exclusion Criteria
- •Infants with congenital malformations, previable rupture of membranes, and acute intrauterine hypoxia.
Outcomes
Primary Outcomes
HFNC slabilization
Time Frame: 10 minutes after delivery
Number of infants who were stabilized after birth on high flow nasal cannula exclusively without any other use of artificial external pressures.